Abstract: Carica papaya leaf samples (Green) were freshly harvested and dried for six consecutive days. The leaves were extracted with methanol; the resulting extracts were screened for the phytochemical constituents using a standard procedure. Phytochemical screening revealed the presence of bioactive compounds such as tannins, saponins, terpenoids, glycosides, and alkaloids. The in vitro anti-diabetic potential of the plant was also determined so as to justify the traditional usage of the plant in treating diabetes. The result of the present study confirmed that the methanolic extract of C. papaya leaves possess significant anti-diabetic activity in vitro, this shows that the leaves has the potential for the development of drugs in combating diabetes.
INTRODUCTION
Human beings have been plagued with diverse types of diseases such as HIV/AIDS, cancer, cholera, hepatitis, leprosy, measles, and diabetes among others. Diabetes mellitus is among the leading causes of death worldwide and it is prevalent in developing nations which may be partly due to the nature of the diets in this part of the world and other factors such as heredity and environmental factors. (1) . This disease is caused by an unusual high concentration of sugar in the blood which might be a direct consequence of deficiency of insulin (2) . The control or the cure of diabetes without side effects is a serious challenge militating against the development of anti-diabetic therapeutics over the centuries. Of core importance to the development of an anti-diabetic therapeutic is controlling hyperglycaemia, which is the milestone of diabetes and its complications. Thus, controlling excess sugar in the blood is the most crucial aim in reducing the risks associated with diabetes and its complications (3). One of the major means of treating the disease includes, but not limited to, insulin and various oral anti-diabetic agents such as sulfonylureas, biguanides and glinides. However, these agents are not devoid of adverse effects as such, there has been renewed search for hypoglycaemic agents with far lesser or no effect whatsoever. Despite the enormous work which have been done to probe the anti-diabetic potency of various parts of C. papaya over the world, report is scanty on the efficacy of the leaves of this plant in lowering the abnormally high blood sugar usually associated with diabetes hence, the present study aimed at investigating the phytochemical profile and also evaluate the in vitro anti-diabetic potency of C. papaya leaves.
MATERIALS AND METHODS

Sample collection
Green leaves of Carica papaya were collected from Islamic village in Ilorin, Ilorin West Local Government, Kwara State, Nigeria. The plant was authenticated at the herbarium of Plant and Environmental Biology Department, Kwara State University Malete, Nigeria.
Preparation of Sample
The leaves were dried under ambient conditions for six consecutive days and subsequently pulverized. A 70-gram-sample of the pulverized leaves was extracted with methanol for 72 hours and the resultant crude extract obtained was filtered. The crude extract was concentrated under reduced pressure using rotary evaporator to obtain a solvent-free methanol extract and stored in an air-tight bottle for further analyses.
Phytochemical analysis
The qualitative phytochemical tests were carried out to determine the presence and absence of various phytochemical constituents such as of alkaloids, saponins, glycosides, terpenoids, and tannins using the standard method (24) .
In vitro anti-diabetic activity test
The Carica papaya leaf extract was subjected to non-enzymatic glycosylation of haemoglobin assay, and α-amylase inhibition assay. Anti-diabetic efficacy of C. papaya was carried out by estimating the degree of non-enzymatic haemoglobin glycosylation, measured colorimetrically at 520 nm. Glucose (2%), haemoglobin (0.06%) and gentamycin (0.02%) solutions were prepared in phosphate buffer 0.01 M and pH 7.4. 1 mL each of above solution was mixed. 1 mL of the concentrated extract was added to the mixture. It was incubated in dark at ambient condition for 72 hrs. The degree of glycosylation of haemoglobin was measured colorimetrically at 520 nm. % inhibition was calculated using standard literature procedure (34) . α-Tocopherol (Trolox) was used as a standard drug for assay (25) . 
Alpha amylase inhibition assay
Glucose uptake in yeast cells
Commercial baker's yeast was washed by repeated centrifugation (3000 g; 5 mins) with distilled water until the supernatant fluids were clean and 10 % (v/v) suspension was prepared in distilled water. Various concentrations of extracts (1-5 mg) were added to 1 mL of glucose solution (5, 10 and 25 mM) and incubated together for 10 mins at 37 ºC. Reaction started by adding 100 mL of yeast suspension, vortexed and further incubated at 37 ºC for 60 mins. After that time, the tubes were centrifuged (2500 g, 5 min) and glucose was estimated in the supernatant. Metronidazole was taken as standard drug (27) . The increase in the percentage of glucose uptake by yeast cells was calculated based on standard literature procedure.
RESULTS AND DISCUSSION
Phytochemical analysis
The result of the qualitative phytochemical screening (secondary metabolites) present in the methanolic extract of C. papaya leaves is presented in Table 1 
α-amylase inhibitory effect of methanolic C.papaya extract
Alpha-amylase is a digestive enzyme found in the secretions of the intestinal mucosa, pancreas, and the saliva. It is responsible for the breakdown of α-1, 4-glycosidic bonds in starch. Thus, the catalytic activities of the enzyme (especially in the small intestine), increase the availability of glucose in the blood, since the pH of the intestine is around 6.9, α-amylase has access to starch at this pH and catalyses the breakdown of this polysaccharide into monosaccharide and disaccharide. At a concentration of 100 μg/mL, C. papaya leaf shows the highest percentage of inhibition of 25.2%. There was a dose dependent increase in percentage inhibitory activity against α-amylase enzyme as shown in Table 2 . From the data, the results suggest that the extract possesses significant inhibitory activity since the percentage inhibition varied from 19.63 to 25.2 in the concentration range of 80 μg/mL -100 μg/mL which was higher when compared to that of the standard drug within the same range. The α-amylase inhibitors act as an anti-nutrient that obstructs the digestion and absorption of carbohydrates (36). Glucose uptake action of methanolic C.papaya extract Glucose transport across yeast cellular membrane occurs via facilitated diffusion down concentration gradient. The rate of glucose transport across the membrane in yeast cell system at different glucose concentrations, i.e. 20, 40, 60, 80, and 100 μg/mL respectively, is presented in Table 3 . The mechanism of glucose transport across the yeast cell membrane has been receiving attention as in vitro screening method for hypoglycaemic effect of various compounds present in medicinal plants. Recent studies on the transport of non metabolizable sugars and certain metabolizable glycosides suggest that sugar transport across the yeast cell membrane is mediated by stereospecific membrane carriers. This implies that the dosedependent increase in the glucose uptake of yeast (Table 3 ) is a reflection of the extract's ability to enhance the utilization of glucose by yeast. This is because transport of glucose is only attained (and continued) if there is removal of intracellular glucose. The result obtained suggest that methanol extract of C. papaya leaves were capable of enhancing glucose uptake (utilization) thereby controlling the blood glucose level (25) . Values are expressed as mean ± SMD. Absorbance of blank=0.225 ±0.00
In vitro non-enzymatic glycosylation of haemoglobin
The inhibitory effect of methanolic C. papaya samples on non-enzymatic glycosylation of haemoglobin is shown in Table 4 . C. papaya exhibits a concentration-dependent increase in % inhibition of glycosylation, which suggests that the plant extract decreases the formation of the glucose haemoglobin complication and thus the amount of free haemoglobin increases.
Interestingly, at a concentration of 100 μg/mL, C. papaya showed the highest percentage inhibition of 20.6% which compared favorably with that of the standard. Increased concentration of glucose in the blood leads to its binding to haemoglobin which may result in the formation of the reactive oxygen species (37). Values are expressed as mean ± SMD. Absorbance of blank= 0.246 ± 0.00
CONCLUSION
The result of the present study demonstrated that the qualitative phytochemical analysis of methanolic extract of C. papaya leaves confirmed the presence of the following phytoconstituents; polyphenol, tannins, saponins, terpenoids, flavonoids, glycosides, and alkaloids. The in vitro anti-diabetic potential of the plant extract was confirmed through α-amylase inhibition, glucose uptake by yeast cells and non-enzymatic glycosylation methods.
The result of this research confirms the claim of Yoruba herbalists in using the leaves of the plant to control diabetes, however; further exploration of the various bioactive compounds should be isolated and developed into drugs to combat the disease. The result of the present study confirmed that the methanolic extract of C. papaya leaves possess significant antidiabetic activity in vitro, this shows that the leaves has the potential for the development of drugs in combating diabetes.
